Cytokine expression and secretion by skeletal muscle cells: Regulatory mechanisms and exercise effects

Exercise Immunology Review

Volumn 21, Issue , 2015, Pages 8-25

  Peake, Jonathan M ^a   Gatta, Paul Della ^b   Suzuki, Katsuhiko ^c   Nieman, David C ^d  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c WASEDA UNIVERSITY   (Japan)

^d APPALACHIAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA BINDING PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE RECEPTOR; IL6 PROTEIN, HUMAN; MESSENGER RNA; MUSCLE PROTEIN;

CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; EXERCISE; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; MYOBLAST; MYOTUBE; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE CELL; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BLOOD; BONE MARROW CELL; CELL CULTURE; CYTOLOGY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; RUNNING; SECRETION (PROCESS); SKELETAL MUSCLE;

ANIMALS; CELLS, CULTURED; CYTOKINES; EXERCISE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MOTOR ACTIVITY; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MYELOID CELLS; MYOBLASTS; ORGAN SPECIFICITY; PHYSICAL EXERTION; RECEPTORS, CYTOKINE; RNA, MESSENGER; RNA-BINDING PROTEINS; RUNNING;

EID: 84928697947     PISSN: 10775552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (240)

1. Abbasi A, Fehrenbach E, Hauth M, Walter M, Hudemann J, Wank V, Niess AM, and Northoff H. Changes in spontaneous and LPS-induced ex vivo cytokine production and mRNA expression in male and female athletes following prolonged exhaustive exercise. Exerc Immunol Rev 19:8-28, 2013.
2. Abou-Khalil R, Mounier R, and Chazaud B. Regulation of myogenic stem cell behavior by vessel cells: the "menage a trois" of satellite cells, periendothelial cells and endothelial cells. Cell Cycle 9:892-896, 2010.
3. Aderka D, Engelmann H, Maor Y, Brakebusch C, and Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329, 1992.
4. Al-Shanti N, Saini A, Faulkner S, and Stewart C. Beneficial synergistic interactions of TNF-α and IL-6 in C2 skeletal myoblasts-potential cross-talk with IGF system. Growth Factors 26:61-73, 2008.
5. Al-Shanti N, and Stewart CE. Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3. J Cell Biochem 113:923-933, 2012.
6. Allen DL, Uyenishi JJ, Cleary AS, Mehan RS, Lindsay SF, and Reed JM. Calcineurin activates interleukin-6 transcription in mouse skeletal muscle in vivo and in C2C12 myotubes in vitro. Am J Physiol Regul Integr Comp Physiol 298:R198-210, 2010.
7. Alvarez B, Quinn LS, Busquets S, Quiles MT, Lopez-Soriano FJ, and Argiles JM. Tumor necrosis factor-α exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells. Biochim Biophys Acta 1542:66-72, 2002.
8. Anegon I, Moreau JF, Godard A, Jacques Y, Peyrat MA, Hallet MM, Wong G, and Soulillou JP. Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol 130:50-65, 1990.
9. Apponi LH, Corbett AH, and Pavlath GK. RNA-binding proteins and gene regulation in myogenesis. Trends Pharmacol Sci 32:652-658, 2011.
10. Arend WP, Malyak M, Smith MF, Jr., Whisenand TD, Slack JL, Sims JE, Giri JG, and Dower SK. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 153:4766-4774, 1994.
11. Armand AS, Bourajjaj M, Martinez-Martinez S, el Azzouzi H, da Costa Martins PA, Hatzis P, Seidler T, Redondo JM, and De Windt LJ. Cooperative synergy between NFAT and MyoD regulates myogenin expression and myogenesis. J Biol Chem 283:29004-29010, 2008.
12. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, and Chazaud B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:1057-1069, 2007.
13. Austin L, and Burgess AW. Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines. J Neurol Sci 101:193-197, 1991.
14. Authier FJ, Chazaud B, Plonquet A, Eliezer-Vanerot MC, Poron F, Belec L, Barlovatz-Meimon G, and Gherardi RK. Differential expression of the IL-1 system components during in vitro myogenesis: implication of IL-1β in induction of myogenic cell apoptosis. Cell Death Differ 6:1012-1021, 1999.
15. Baeza-Raja B, and Munoz-Canoves P. p38 MAPK-induced nuclear factor-κB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell 15:2013-2026, 2004.
16. Bartlett JD, Hwa Joo C, Jeong TS, Louhelainen J, Cochran AJ, Gibala MJ, Gregson W, Close GL, Drust B, and Morton JP. Matched work high-intensity interval and continuous running induce similar increases in PGC-1α mRNA, AMPK, p38, and p53 phosphorylation in human skeletal muscle. J Appl Physiol 112:1135-1143, 2012.
17. Bartoccioni E, Michaelis D, and Hohlfeld R. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol Lett 42:135-138, 1994.
18. Bassit RA, Sawada LA, Bacurau RF, Navarro F, Martins E, Jr., Santos RV, Caperuto EC, Rogeri P, and Costa Rosa LF. Branched-chain amino acid supplementation and the immune response of long-distance athletes. Nutrition 18:376-379, 2002.
19. Baum M, Muller-Steinhardt M, Liesen H, and Kirchner H. Moderate and exhaustive endurance exercise influences the interferon-γ levels in whole-blood culture supernatants. Eur J Appl Physiol 76:165-169, 1997.
20. Bernecker C, Scherr J, Schinner S, Braun S, Scherbaum WA, and Halle M. Evidence for an exercise induced increase of TNF-α and IL-6 in marathon runners. Scand J Med Sci Sports 23:207-214, 2013.
21. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Orjalo AV, Rodier F, Lithgow GJ, and Campisi J. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging 1:402-411, 2009.
22. Birot OJ, Koulmann N, Peinnequin A, and Bigard XA. Exerciseinduced expression of vascular endothelial growth factor mRNA in rat skeletal muscle is dependent on fibre type. J Physiol 552:213-221, 2003.
23. Borge BA, Kalland KH, Olsen S, Bletsa A, Berggreen E, and Wiig H. Cytokines are produced locally by myocytes in rat skeletal muscle during endotoxemia. Am J Physiol Heart Circ Physiol 296:H735-744, 2009.
24. Boyd JH, Divangahi M, Yahiaoui L, Gvozdic D, Qureshi S, and Petrof BJ. Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-κB and calcineurin. Infect Immun 74:6829-6838, 2006.
25. Broholm C, Laye M, Brandt C, Vadalasetty R, Pilegaard H, Pedersen BK, and Scheele C. LIF is a contraction-induced myokine stimulating human myocyte proliferation. J Appl Physiol 111:251-259, 2011.
26. Broholm C, Mortensen OH, Nielsen S, Akerstrom T, Zankari A, Dahl B, and Pedersen BK. Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle. J Physiol 586:2195-2201, 2008.
27. Brunelli A, Dimauro I, Sgro P, Emerenziani GP, Magi F, Baldari C, Guidetti L, Luigi LD, Parisi P, and Caporossi D. Acute exercise modulates BDNF and pro-BDNF protein content in immune cells. Med Sci Sports Exerc 44:1871-1880, 2012.
28. Brutsaert TD, Gavin TP, Fu Z, Breen EC, Tang K, Mathieu-Costello O, and Wagner PD. Regional differences in expression of VEGF mRNA in rat gastrocnemius following 1 hr exercise or electrical stimulation. BMC Physiol 2:8, 2002.
29. Buford TW, Cooke MB, and Willoughby DS. Resistance exerciseinduced changes of inflammatory gene expression within human skeletal muscle. Eur J Appl Physiol 107:463-471, 2009.
30. Buler M, Aatsinki SM, Skoumal R, Komka Z, Toth M, Kerkela R, Georgiadi A, Kersten S, and Hakkola J. Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist. J Biol Chem 287:1847-1860, 2012.
31. Bustamante M, Fernandez-Verdejo R, Jaimovich E, and Buvinic S. Electrical stimulation induces IL-6 in skeletal muscle through extracellular ATP by activating Ca2+ signals and an IL-6 autocrine loop. Am J Physiol Endocrinol Metab 306:E869-882, 2014.
32. Cannon JG, and Kluger MJ. Endogenous pyrogen activity in human plasma after exercise. Science 220:617-619, 1983.
33. Carballo E, Lai WS, and Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281:1001-1005, 1998.
34. Cardinali B, Castellani L, Fasanaro P, Basso A, Alema S, Martelli F, and Falcone G. MicroRNA-221 and microRNA-222 modulate differentiation and maturation of skeletal muscle cells. PLoS One 4:e7607, 2009.
35. Carmichael MD, Davis JM, Murphy EA, Carson JA, Van Rooijen N, Mayer E, and Ghaffar A. Role of brain macrophages on IL-1β and fatigue following eccentric exerciseinduced muscle damage. Brain Behav Immun 24:564-568, 2010.
36. Cassatella MA, Bazzoni F, Ceska M, Ferro I, Baggiolini M, and Berton G. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucylphenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J Immunol 148:3216-3220, 1992.
37. Catoire M, Mensink M, Kalkhoven E, Schrauwen P, and Kersten S. Identification of human exercise-induced myokines using secretome analysis. Physiol Genomics 46:256-267, 2014.
38. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, and Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocytederived dendritic cells. Proc Natl Acad Sci USA 106:2735-2740, 2009.
39. Chan MH, Carey AL, Watt MJ, and Febbraio MA. Cytokine gene expression in human skeletal muscle during concentric contraction: evidence that IL-8, like IL-6, is influenced by glycogen availability. Am J Physiol Regul Integr Comp Physiol 287:R322-R327, 2004.
40. Chazaud B, Sonnet C, Lafuste P, Bassez G, Rimaniol AC, Poron F, Authier FJ, Dreyfus PA, and Gherardi RK. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol 163:1133-1143, 2003.
41. Chen CW, Montelatici E, Crisan M, Corselli M, Huard J, Lazzari L, and Peault B. Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev 20:429-434, 2009.
42. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, and Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228-233, 2006.
43. Chen SE, Jin B, and Li YP. TNF-α regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol 292:C1660-1671, 2007.
44. Chevrel G, Granet C, and Miossec P. Contribution of tumour necrosis factor á and interleukin (IL) 1β to IL6 production, NF-κB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis 64:1257-1262, 2005.
45. Christiansen T, Bruun JM, Paulsen SK, Olholm J, Overgaard K, Pedersen SB, and Richelsen B. Acute exercise increases circulating inflammatory markers in overweight and obese compared with lean subjects. Eur J Appl Physiol 113:1635-1642, 2013.
46. De Bleecker JL, De Paepe B, Vanwalleghem IE, and Schroder JM. Differential expression of chemokines in inflammatory myopathies. Neurology 58:1779-1785, 2002.
47. De Rossi M, Bernasconi P, Baggi F, de Waal Malefyt R, and Mantegazza R. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 12:1329-1335, 2000.
48. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, and de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991.
49. Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, and Saklatvala J. The 3' untranslated region of tumor necrosis factor á mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 21:721-730, 2001.
50. Della Gatta PA, Cameron-Smith D, and Peake JM. Acute resistance exercise increases the expression of chemotactic factors within skeletal muscle. Eur J Appl Physiol 11:2157-2167, 2014.
51. Della Gatta PA, Garnham AP, Peake JM, and Cameron-Smith D. Effect of exercise training on skeletal muscle cytokine expression in the elderly. Brain Behav Immun 39:80-86, 2014.
52. Dennis RA, Trappe TA, Simpson P, Carroll C, Huang BE, Nagarajan R, Bearden E, Gurley C, Duff GW, Evans WJ, Kornman K, and Peterson CA. Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise. J Physiol 560:617-626, 2004.
53. Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, and Brizzi MF. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 30:1562-1568, 2010.
54. Dinarello CA, Ikejima T, Warner SJ, Orencole SF, Lonnemann G, Cannon JG, and Libby P. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 139:1902-1910, 1987.
55. Dittrich E, Rose-John S, Gerhartz C, Mullberg J, Stoyan T, Yasukawa K, Heinrich PC, and Graeve L. Identification of a region within the cytoplasmic domain of the interleukin-6 (IL-6) signal transducer gp130 important for ligand-induced endocytosis of the IL-6 receptor. J Biol Chem 269:19014-19020, 1994.
56. Drenth J, Van Uum S, Van Deuren M, GJ P, Van Der Ven-Jongekrijg J, and Van Der Meer J. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-α and IL-1β production. J Appl Physiol 79:1497-1503, 1995.
57. Drenth JP, Krebbers RJ, Bijzet J, and van der Meer JW. Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1β production but decreased tumour necrosis factor-α production after a 5-km run. Eur J Clin Invest 28:866-872, 1998.
58. Dubravec DB, Spriggs DR, Mannick JA, and Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor α. Proc Natl Acad Sci USA 87:6758-6761, 1990.
59. El Gazzar M, and McCall CE. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J Biol Chem 285:20940-20951, 2010.
60. Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, Hotamisligil GS, and Van Obberghen E. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice. J Biol Chem 276:47944-47949, 2001.
61. Ensor JE, Wiener SM, McCrea KA, Viscardi RM, Crawford EK, and Hasday JD. Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-α expression. Am J Physiol Cell Physiol 266:C967-974, 1994.
62. Farmawati A, Kitajima Y, Nedachi T, Sato M, Kanzaki M, and Nagatomi R. Characterization of contraction-induced IL-6 upregulation using contractile C2C12 myotubes. Endocr J 60:137-147, 2013.
63. Febbraio MA, Steensberg A, Fischer CP, Keller C, Hiscock N, and Pedersen BK. IL-6 activates HSP72 gene expression in human skeletal muscle. Biochem Biophys Res Commun 296:1264-1266, 2002.
64. Febbraio MA, Steensberg A, Keller C, Starkie RL, Nielsen HB, Krustrup P, Ott P, Secher NH, and Pedersen BK. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J Physiol 549:607-612, 2003.
65. Febbraio MA, Steensberg A, Starkie RL, McConell GK, and Kingwell BA. Skeletal muscle interleukin-6 and tumor necrosis factor-α release in healthy subjects and patients with type 2 diabetes at rest and during exercise. Metabolism 52:939-944, 2003.
66. Fielding R, Manfredi T, Ding W, Fiatarone M, Evans W, and Cannon J. Acute phase response in exercise III. Neutrophil and IL-1β accumulation in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 265:R166-R172, 1993.
67. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991.
68. Fischer C, Hiscock N, Penkowa M, Basu S, Vessby B, Kallner A, Sjoberg L-B, and Pedersen B. Vitamin C and E supplementation inhibits the release of interleukin-6 from contracting human skeletal muscle. J Physiol 558:633-645, 2004.
69. Frost R, Nystrom G, and Lang C. Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes. Am J Physiol Regul Integr Comp Physiol 290:R773-784, 2006.
70. Frost RA, Nystrom GJ, and Lang CH. Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun. NH2-terminal kinase and histone deacetylase activity. Am J Physiol Endocrinol Metab 286:E809-817, 2004.
71. Frost RA, Nystrom GJ, and Lang CH. Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun. NH2-terminal kinase. Am J Physiol Regul Integr Comp Physiol 285:R1153-1164, 2003.
72. Frost RA, Nystrom GJ, and Lang CH. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. Am J Physiol Regul Integr Comp Physiol 283:R698-709, 2002.
73. Gallucci S, Provenzano C, Mazzarelli P, Scuderi F, and Bartoccioni E. Myoblasts produce IL-6 in response to inflammatory stimuli. Int Immunol 10:267-273, 1998.
74. Ge Y, Waldemer RJ, Nalluri R, Nuzzi PD, and Chen J. RNAi screen reveals potentially novel roles of cytokines in myoblast differentiation. PLoS One 8:e68068, 2013.
75. Geyer BC, Ben Ari S, Barbash S, Kilbourne J, Mor TS, and Soreq H. Nicotinic stimulation induces Tristetraprolin overproduction and attenuates inflammation in muscle. Biochim Biophys Acta 1823:368-378, 2012.
76. Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, Roach JC, Kennedy K, Hai T, Bolouri H, and Aderem A. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441:173-178, 2006.
77. Giresi PG, Stevenson EJ, Theilhaber J, Koncarevic A, Parkington J, Fielding RA, and Kandarian SC. Identification of a molecular signature of sarcopenia. Physiol Genomics 21:253-263, 2005.
78. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, and Ahdieh M. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965-968, 1994.
79. Graeve L, Korolenko TA, Hemmann U, Weiergraber O, Dittrich E, and Heinrich PC. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130. FEBS Lett 399:131-134, 1996.
80. Griffin CA, Apponi LH, Long KK, and Pavlath GK. Chemokine expression and control of muscle cell migration during myogenesis. J Cell Sci 123:3052-3060, 2010.
81. Haahr PM, Pedersen BK, Fomsgaard A, Tvede N, Diamant M, Klarlund K, Halkjaer-Kristensen J, and Bendtzen K. Effect of physical exercise on in vitro production of interleukin 1, interleukin 6, tumour necrosis factor-α, interleukin 2 and interferon-γ. Int J Sports Med 12:223-227, 1991.
82. Hamada K, Vannier E, Sacheck JM, Witsell AL, and Roubenoff R. Senescence of human skeletal muscle impairs the local inflammatory cytokine response to acute eccentric exercise. FASEB J 19:264-266, 2005.
83. Haugen F, Norheim F, Lian H, Wensaas AJ, Dueland S, Berg O, Funderud A, Skalhegg BS, Raastad T, and Drevon CA. IL-7 is expressed and secreted by human skeletal muscle cells. Am J Physiol Cell Physiol 298:C807-816, 2010.
84. Heaney ML, and Golde DW. Soluble cytokine receptors. Blood 87:847-857, 1996.
85. Henningsen J, Pedersen BK, and Kratchmarova I. Quantitative analysis of the secretion of the MCP family of chemokines by muscle cells. Mol Biosyst 7:311-321, 2011.
86. Henningsen J, Rigbolt KT, Blagoev B, Pedersen BK, and Kratchmarova I. Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics 2010.
87. Henson DA, Nieman DC, Blodgett AD, Butterworth DE, Utter A, Davis JM, Sonnenfeld G, Morton DS, Fagoaga OR, and Nehlsen-Cannarella SL. Influence of exercise mode and carbohydrate on the immune response to prolonged exercise. Int J Sport Nutr 9:213-228, 1999.
88. Higuchi M, and Aggarwal BB. TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol 152:3550-3558, 1994.
89. Hiscock N, Chan MH, Bisucci T, Darby IA, and Febbraio MA. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J 18:992-994, 2004.
90. Hoier B, Prats C, Qvortrup K, Pilegaard H, Bangsbo J, and Hellsten Y. Subcellular localization and mechanism of secretion of vascular endothelial growth factor in human skeletal muscle. FASEB J 27:3496-3504, 2013.
91. Hoier B, Walker M, Passos M, Walker PJ, Green A, Bangsbo J, Askew CD, and Hellsten Y. Angiogenic response to passive movement and active exercise in individuals with peripheral arterial disease. J Appl Physiol 115:1777-1787, 2013.
92. Holmes AG, Watt MJ, Carey AL, and Febbraio MA. Ionomycin, but not physiologic doses of epinephrine, stimulates skeletal muscle interleukin-6 mRNA expression and protein release. Metabolism 53:1492-1495, 2004.
93. Horii Y, Muraguchi A, Suematsu S, Matsuda T, Yoshizaki K, Hirano T, and Kishimoto T. Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 141:1529-1535, 1988.
94. Hubal MJ, Chen TC, Thompson PD, and Clarkson PM. Inflammatory gene changes associated with the repeated-bout effect. Am J Physiol Regul Integr Comp Physiol 294:R1628-1637, 2008.
95. Huey KA, and Meador BM. Contribution of IL-6 to the Hsp72, Hsp25, and αB-crystallin responses to inflammation and exercise training in mouse skeletal and cardiac muscle. J Appl Physiol 105:1830-1836, 2008.
96. Jacquemin V, Butler-Browne GS, Furling D, and Mouly V. IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes. J Cell Sci 120:670-681, 2007.
97. Jiang LQ, Franck N, Egan B, Sjogren RJ, Katayama M, Duque-Guimaraes D, Arner P, Zierath JR, and Krook A. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. Am J Physiol Endocrinol Metab 305:E1359-1366, 2013.
98. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H, and Han J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120:623-634, 2005.
99. Kakanis MW, Peake J, Brenu EW, Simmonds M, Gray B, and Marshall-Gradisnik SM. T helper cell cytokine profiles after endurance exercise. J Interferon Cytokine Res 34:699-706:2014.
100. Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, and Dinarello CA. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84:4242-4248, 1994.
101. Katsanou V, Papadaki O, Milatos S, Blackshear PJ, Anderson P, Kollias G, and Kontoyiannis DL. HuR as a negative posttranscriptional modulator in inflammation. Mol Cell 19:777-789, 2005.
102. Keller C, Hellsten Y, Steensberg A, and Pedersen BK. Differential regulation of IL-6 and TNF-α via calcineurin in human skeletal muscle cells. Cytokine 36:141-147, 2006.
103. Keller C, Keller P, Marshal S, and Pedersen BK. IL-6 gene expression in human adipose tissue in response to exercise - effect of carbohydrate ingestion. J Physiol 550:927-931, 2003.
104. Keller P, Penkowa M, Keller C, Steensberg A, Fischer CP, Giralt M, Hidalgo J, and Pedersen BK. Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J 19:1181-1183, 2005.
105. Kim HK, Lee YS, Sivaprasad U, Malhotra A, and Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 174:677-687, 2006.
106. Kim JA, Park HS, Kang SR, Park KI, Lee DH, Nagappan A, Shin SC, Lee WS, Kim EH, and Kim GS. Suppressive effect of flavonoids from Korean citrus aurantium L. on the expression of inflammatory mediators in L6 skeletal muscle cells. Phytother Res 26:1906-12, 2012.
107. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, and Roussos C. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. Am J Respir Cell Mol Biol 26:587-593, 2002.
108. Kovac A, Erickson MA, and Banks WA. Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J Neuroinflammation 8:139-148, 2011.
109. Krogh-Madsen R, Plomgaard P, Moller K, Mittendorfer B, and Pedersen BK. Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am J Physiol Endocrinol Metab 291:E108-114, 2006.
110. Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, and Austin L. The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve 20:815-822, 1997.
111. Kurt-Jones EA, Fiers W, and Pober JS. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J Immunol 139:2317-2324, 1987.
112. Kvernmo H, Olsen JO, and Osterud B. Changes in blood cell response following strenuous physical exercise. Eur J Appl Physiol Occup Physiol 64:318-322, 1992.
113. Lancaster GI, Halson SL, Khan Q, Drysdale P, Wallace F, Jeukendrup AE, Drayson MT, and Gleeson M. Effects of acute exhaustive exercise and chronic exercise training on type 1 and type 2 T lymphocytes. Exerc Immunol Rev 10:91-106, 2004.
114. Langberg H, Olesen JL, Gemmer C, and Kjaer M. Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol 542:985-990, 2002.
115. Langen RC, Schols AM, Kelders MC, Wouters EF, and Janssen-Heininger YM. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB. FASEB J 15:1169-1180, 2001.
116. Lauritzen HP, Brandauer J, Schjerling P, Koh HJ, Treebak JT, Hirshman MF, Galbo H, and Goodyear LJ. Contraction and AICAR stimulate IL-6 vesicle depletion from skeletal muscle fibers in vivo. Diabetes 62:3081-3092, 2013.
117. La Voy EC, Bosch JA, Lowder TW, and Simpson RJ. Acute aerobic exercise in humans increases cytokine expression in CD27 (-) but not CD27 (+) CD8 (+) T-cells. Brain Behav Immun 27:54-62, 2013.
118. Le JM, Weinstein D, Gubler U, and Vilcek J. Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. J Immunol 138:2137-2142, 1987.
119. Lee WJ. IGF-I exerts an anti-inflammatory effect on skeletal muscle cells through down-regulation of TLR4 signaling. Immune Netw 11:223-226, 2011.
120. Leggate M, Nowell MA, Jones SA, and Nimmo MA. The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cycling. Cell Stress Chaperones 15:827-833, 2010.
121. Li Y, and Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161:895-907, 2002.
122. Li YP. TNF-α is a mitogen in skeletal muscle. Am J Physiol Cell Physiol 285:C370-376, 2003.
123. Liebler JM, Kunkel SL, Burdick MD, Standiford TJ, Rolfe MW, and Strieter RM. Production of IL-8 and monocyte chemotactic peptide-1 by peripheral blood monocytes. Disparate responses to phytohemagglutinin and lipopolysaccharide. J Immunol 152:241-249, 1994.
124. Louis E, Raue U, Yang Y, Jemiolo B, and Trappe S. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol 103:1744-1751, 2007.
125. Luo G, Hershko DD, Robb BW, Wray CJ, and Hasselgren PO. IL-1β stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-κB. Am J Physiol Regul Integr Comp Physiol 284:R1249-1254, 2003.
126. Lyngso D, Simonsen L, and Bulow J. Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol 543:373-378, 2002.
127. Ma F, Liu X, Li D, Wang P, Li N, Lu L, and Cao X. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolinmediated IL-10 mRNA degradation. J Immunol 184:6053-6059, 2010.
128. Makris AC, Sotzios Y, Zhou Z, Makropoulou M, Papapetropoulos N, Zacharatos P, Pyriochou A, Roussos C, Papapetropoulos A, and Vassilakopoulos T. Nitric oxide stimulates interleukin-6 production in skeletal myotubes. J Interferon Cytokine Res 30:321-327, 2010.
129. Malm C, Nyberg P, Engstrom M, Sjodin B, Lenkei R, Ekblom B, and Lundberg I. Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol 529:243-262, 2000.
130. Malm C, Sjodin TL, Sjoberg B, Lenkei R, Renstrom P, Lundberg IE, and Ekblom B. Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running. J Physiol 556:983-1000, 2004.
131. Mannel DN, Moore RN, and Mergenhagen SE. Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun 30:523-530, 1980.
132. Marie C, Pitton C, Fitting C, and Cavaillon JM. IL-10 and IL-4 synergize with TNF-α to induce IL-1ra production by human neutrophils. Cytokine 8:147-151, 1996.
133. Marino M, Scuderi F, Provenzano C, Scheller J, Rose-John S, and Bartoccioni E. IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. J Neuroimmunol 196:41-48, 2008.
134. Marker T, Sell H, Zillessen P, Glode A, Kriebel J, Ouwens DM, Pattyn P, Ruige J, Famulla S, Roden M, Eckel J, and Habich C. Heat shock protein 60 as a mediator of adipose tissue inflammation and insulin resistance. Diabetes 61:615-625, 2012.
135. Markovitch D, Tyrrell RM, and Thompson D. Acute moderateintensity exercise in middle-aged men has neither an anti-nor proinflammatory effect. J Appl Physiol 105:260-265, 2008.
136. Martel-Pelletier J, McCollum R, and Pelletier JP. The synthesis of IL-1 receptor antagonist (IL-1ra) by synovial fibroblasts is markedly increased by the cytokines TNF-α and IL-1. Biochim Biophys Acta 1175:302-305, 1993.
137. Matthews VB, Astrom MB, Chan MH, Bruce CR, Krabbe KS, Prelovsek O, Akerstrom T, Yfanti C, Broholm C, Mortensen OH, Penkowa M, Hojman P, Zankari A, Watt MJ, Bruunsgaard H, Pedersen BK, and Febbraio MA. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMPactivated protein kinase. Diabetologia 52:1409-1418, 2009.
138. McKay BR, De Lisio M, Johnston AP, O'Reilly CE, Phillips SM, Tarnopolsky MA, and Parise G. Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans. PLoS One 4:e6027, 2009.
139. McKinsey TA, Zhang CL, Lu J, and Olson EN. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106-111, 2000.
140. McMullen MR, Cocuzzi E, Hatzoglou M, and Nagy LE. Chronic ethanol exposure increases the binding of HuR to the TNFα 3'-untranslated region in macrophages. J Biol Chem 278:38333-38341, 2003.
141. Melo F, Carey DJ, and Brandan E. Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression. J Cell Biochem 62:227-239, 1996.
142. Meng X, Banerjee A, Ao L, Meldrum DR, Cain BS, Shames BD, and Harken AH. Inhibition of myocardial TNF-α production by heat shock. A potential mechanism of stress-induced cardioprotection against postischemic dysfunction. Ann NY Acad Sci 874:69-82, 1999.
143. Miura P, Amirouche A, Clow C, Belanger G, and Jasmin BJ. Brain-derived neurotrophic factor expression is repressed during myogenic differentiation by miR-206. J Neurochem 120:230-238, 2012.
144. Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, and Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 113:407-414, 1998.
145. Naka T, Narazaki M, and Kishimoto T. Negative-feedback regulation of cytokine signals. In: Cytokine inhibitors, edited by Ciliberto G. New York: Marcel Dekker, 2000, p. 241-260.
146. Nedachi T, Fujita H, and Kanzaki M. Contractile C2C12 myotube model for studying exercise-inducible responses in skeletal muscle. Am J Physiol Endocrinol Metab 295:E1191-E1204, 2008.
147. Neubauer O, Sabapathy S, Ashton KJ, Desbrow B, Peake JM, Lazarus R, Wessner B, Cameron-Smith D, Wagner KH, Haseler LJ, and Bulmer AC. Time course-dependent changes in the transcriptome of human skeletal muscle during recovery from endurance exercise: from inflammation to adaptive remodeling. J Appl Physiol 116:274-287, 2014.
148. Nguyen HX, and Tidball JG. Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice. J Physiol 553:833-841, 2003.
149. Nielsen AR, Mounier R, Plomgaard P, Mortensen OH, Penkowa M, Speerschneider T, Pilegaard H, and Pedersen BK. Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol 584:305-312, 2007.
150. Nieman DC, Davis JM, Brown VA, Henson DA, Dumke CL, Utter AC, Vinci DM, Downs MF, Smith JC, Carson J, Brown A, McAnulty SR, and McAnulty LS. Influence of carbohydrate ingestion on immune changes after 2 h of intensive resistance training. J Appl Physiol 96:1292-1298, 2004.
151. Nieman DC, Davis JM, Henson DA, Gross SJ, Dumke CL, Utter AC, Vinci DM, Carson JA, Brown A, McAnulty SR, McAnulty LS, and Triplett NT. Muscle cytokine mRNA changes after 2.5 h of cycling: influence of carbohydrate. Med Sci Sports Exerc 37:1283-1290, 2005.
152. Nieman DC, Davis JM, Henson DA, Walberg-Rankin J, Shute M, Dumke CL, Utter AC, Vinci DM, Carson JA, Brown A, Lee WJ, McAnulty SR, and McAnulty LS. Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J Appl Physiol 94:1917-1925, 2003.
153. Nieman DC, Dumke CL, Henson DA, McAnulty SR, Gross SJ, and Lind RH. Muscle damage is linked to cytokine changes following a 160-km race. Brain Behav Immun 19:398-403, 2005.
154. Nieman DC, Henson DA, Davis JM, Angela Murphy E, Jenkins DP, Gross SJ, Carmichael MD, Quindry JC, Dumke CL, Utter AC, McAnulty SR, McAnulty LS, Triplett NT, and Mayer EP. Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol 103:1728-1735, 2007.
155. Nieman DC, Henson DA, Smith LL, Utter AC, Vinci DM, Davis JM, Kaminsky DE, and Shute M. Cytokine changes after a marathon race. J Appl Physiol 91:109-114, 2001.
156. Nieman DC, Konrad M, Henson DA, Kennerly K, Shanely RA, and Wallner-Liebmann SJ. Variance in the acute inflammatory response to prolonged cycling is linked to exercise intensity. J Interferon Cytokine Res 32:12-17, 2012.
157. Nieman DC, Luo B, Dreau D, Henson DA, Shanely RA, Dew D, and Meaney MP. Immune and inflammation responses to a 3-day period of intensified running versus cycling. Brain Behav Immun 39:180-185, 2014.
158. Nybo L, Nielsen B, Pedersen BK, Moller K, and Secher NH. Interleukin-6 release from the human brain during prolonged exercise. J Physiol 542:991-995, 2002.
159. Ohno Y, Yamada S, Sugiura T, Ohira Y, Yoshioka T, and Goto K. Possible role of NF-kB signals in heat stress-associated increase in protein content of cultured C2C12 cells. Cells Tissues Organs 194:363-370, 2011.
160. Ostrowski K, Rohde T, Asp S, Schjerling P, and Pedersen BK. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515:287-291, 1999.
161. Ostrowski K, Rohde T, Zacho M, Asp S, and Pedersen B. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 508:949-953, 1998.
162. Otis JS, Niccoli S, Hawdon N, Sarvas JL, Frye MA, Chicco AJ, and Lees SJ. Pro-inflammatory mediation of myoblast proliferation. PLoS One 9:e92363, 2014.
163. Pang G, Couch L, Batey R, Clancy R, and Cripps A. GM-CSF, IL-1α, IL-1β, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1α and TNF-α. Clin Exp Immunol 96:437-443, 1994.
164. Peake JM, Suzuki K, Hordern M, Wilson G, Nosaka K, and Coombes JS. Plasma cytokine changes in relation to exercise intensity and muscle damage. Eur J Appl Physiol 95:514-521, 2005.
165. Peake JM, Wilson G, Hordern M, Suzuki K, Nosaka K, Yamaya K, Mackinnon L, and Coombes J. Changes in neutrophil receptor expression, degranulation and respiratory burst activity after moderate and high intensity exercise. J Appl Physiol 97:612-618, 2004.
166. Pedersen BK. Muscles and their myokines. J Exp Biol 214:337-346, 2011.
167. Pedersen BK, and Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88:1379-1406, 2008.
168. Pedersen BK, and Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457-465, 2012.
169. Perdiguero E, Ruiz-Bonilla V, Serrano AL, and Munoz-Canoves P. Genetic deficiency of p38α reveals its critical role in myoblast cell cycle exit: the p38α-JNK connection. Cell Cycle 6:1298-1303, 2007.
170. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, and Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1β-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 180:5689-5698, 2008.
171. Petersen AM, and Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 98:1154-1162, 2005.
172. Peterson J, and Pizza F. Cytokines derived from cultured skeletal muscle cells after mechanical strain promote neutrophil chemotaxis in vitro. J Appl Physiol 106:130-137, 2009.
173. Phillips MD, Flynn MG, McFarlin BK, Stewart LK, Timmerman KL, and Ji H. Resistive exercise blunts LPS-stimulated TNF-α and IL-1β. Int J Sports Med 29:102-109, 2008.
174. Pizza FX, McLoughlin TJ, McGregor SJ, Calomeni EP, and Gunning WT. Neutrophils injure cultured skeletal myotubes. Am J Physiol Cell Physiol 281:C335-341, 2001.
175. Plomgaard P, Penkowa M, and Pedersen BK. Fiber type specific expression of TNF-α, IL-6 and IL-18 in human skeletal muscles. Exerc Immunol Rev 11:53-63, 2005.
176. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, and Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25:1737-1745, 2007.
177. Porteu F, and Hieblot C. Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J Biol Chem 269:2834-2840, 1994.
178. Prelovsek O, Mars T, Jevsek M, Podbregar M, and Grubic Z. High dexamethasone concentration prevents stimulatory effects of TNF-α and LPS on IL-6 secretion from the precursors of human muscle regeneration. Am J Physiol Regul Integr Comp Physiol 291:R1651-1656, 2006.
179. Pue CA, Mortensen RF, Marsh CB, Pope HA, and Wewers MD. Acute phase levels of C-reactive protein enhance IL-1β and IL-1ra production by human blood monocytes but inhibit IL-1β and IL-1ra production by alveolar macrophages. J Immunol 156:1594-1600, 1996.
180. Quinn LS, Strait-Bodey L, Anderson BG, Argiles JM, and Havel PJ. Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol Int 29:449-457, 2005.
181. Rajasingh J, Bord E, Luedemann C, Asai J, Hamada H, Thorne T, Qin G, Goukassian D, Zhu Y, Losordo DW, and Kishore R. IL-10-induced TNF-α mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J 20:2112-2114, 2006.
182. Raschke S, Eckardt K, Bjorklund Holven K, Jensen J, and Eckel J. Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells. PLoS One 8:e62008, 2013.
183. Raschke S, and Eckel J. Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise. Mediators Inflamm 2013:320724, 2013.
184. Reihmane D, Jurka A, Tretjakovs P, and Dela F. Increase in IL-6, TNF-α, and MMP-9, but not sICAM-1, concentrations depends on exercise duration. Eur J Appl Physiol 113:851-858, 2013.
185. Rhind SG, Castellani JW, Brenner IK, Shephard RJ, Zamecnik J, Montain SJ, Young AJ, and Shek PN. Intracellular monocyte and serum cytokine expression is modulated by exhausting exercise and cold exposure. Am J Physiol Regul Integr Comp Physiol 281:R66-R75, 2001.
186. Riechman SE, Balasekaran G, Roth SM, and Ferrell RE. Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol 97:2214-2219, 2004.
187. Riedemann NC, Guo RF, Hollmann TJ, Gao H, Neff TA, Reuben JS, Speyer CL, Sarma JV, Wetsel RA, Zetoune FS, and Ward PA. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 18:370-372, 2004.
188. Rippe C, Blimline M, Magerko KA, Lawson BR, La Rocca TJ, Donato AJ, and Seals DR. MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation. Exp Gerontol 47:45-51, 2012.
189. Rivier A, Pene J, Chanez P, Anshelme F, Caillaud C, Prefaut C, Godard P, and Bousquet J. Release of cytokines by blood monocytes during strenuous exercise. International Journal of Sports Medicine 15:192-198, 1994.
190. Rojas Vega S, Knicker A, Hollmann W, Bloch W, and Struder HK. Effect of resistance exercise on serum levels of growth factors in humans. Horm Metab Res 42:982-986, 2010.
191. Rosendal L, Sogaard K, Kjaer M, Sjogaard G, Langberg H, and Kristiansen J. Increase in interstitial interleukin-6 of human skeletal muscle with repetitive low-force exercise. J Appl Physiol 98:477-481, 2005.
192. Ross ML, Halson SL, Suzuki K, Garnham A, Hawley JA, Cameron-Smith D, and Peake JM. Cytokine responses to carbohydrate ingestion during recovery from exercise-induced muscle injury. J Interferon Cytokine Res 30:329-337, 2010.
193. Sachidanandan C, Sambasivan R, and Dhawan J. Tristetraprolin and LPS-inducible CXC chemokine are rapidly induced in presumptive satellite cells in response to skeletal muscle injury. J Cell Sci 115:2701-2712, 2002.
194. Salomonsson S, and Lundberg IE. Cytokines in idiopathic inflammatory myopathies. Autoimmunity 39:177-190, 2006.
195. Scheler M, Irmler M, Lehr S, Hartwig S, Staiger H, Al-Hasani H, Beckers J, de Angelis MH, Haring HU, and Weigert C. Cytokine response of primary human myotubes in an in vitro exercise model. Am J Physiol Cell Physiol 305:C877-886, 2013.
196. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, and Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40-47, 1990.
197. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, and Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 7:33-44, 2008.
198. Sharma A, Kumar M, Aich J, Hariharan M, Brahmachari SK, Agrawal A, and Ghosh B. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. Proc Natl Acad Sci USA 106:5761-5766, 2009.
199. Shin JN, Kim I, Lee JS, Koh GY, Lee ZH, and Kim HH. A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6. J Biol Chem 277:8346-8353, 2002.
200. Simbertsev A, and Kozlov I. Cytokine system. In: Mechanical stretch and cytokines [e-book], edited by Kamkin A, and Kiseleva I. Dordrecht: Springer Science+Business Media B. V., 2012, p. 1-6.
201. Smith CA, Stauber F, Waters C, Alway SE, and Stauber WT. Transforming growth factor-β following skeletal muscle strain injury in rats. J Appl Physiol 102:755-761, 2007.
202. Smits HH, Grunberg K, Derijk RH, Sterk PJ, and Hiemstra PS. Cytokine release and its modulation by dexamethasone in whole blood following exercise. Clin Exp Immunol 111:463-468, 1998.
203. Snell ES, and Atkins E. The presence of endogenous pyrogen in normal rabbit tissues. J Exp Med 121:1019-1038, 1965.
204. Spangenburg EE, Brown DA, Johnson MS, and Moore RL. Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. J Physiol 572:839-848, 2006.
205. Stamou P, and Kontoyiannis DL. Posttranscriptional regulation of TNF mRNA: a paradigm of signal-dependent mRNA utilization and its relevance to pathology. Curr Dir Autoimmun 11:61-79, 2010.
206. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, and Pedersen BK. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans. FASEB J 17:884-886, 2003.
207. Starkie RL, Angus DJ, Rolland J, Hargreaves M, and Febbraio MA. Effect of prolonged, submaximal exercise and carbohydrate ingestion on monocyte intracellular cytokine production in humans. J Physiol 528:647-655, 2000.
208. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA, and Febbraio MA. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 533:585-591, 2001.
209. Starkie RL, Hargreaves M, Rolland J, and Febbraio M. Heat stress, cytokines and the immune response to exercise. Brain Behav Immun 19:404-412, 2005.
210. Starkie RL, Rolland J, Angus DJ, Anderson MJ, and Febbraio MA. Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-α levels after prolonged running. Am J Physiol Cell Physiol 280:C769-C774, 2001.
211. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, and Pedersen BK. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 537:633-639, 2001.
212. Steensberg A, Keller C, Starkie R, Osada T, Febbraio M, and Pedersen B. IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 283:E1272-E1278, 2002.
213. Steensberg A, Toft AD, Bruunsgaard H, Sandmand M, Halkjaer-Kristensen J, and Pedersen BK. Strenuous exercise decreases the percentage of type 1 T cells in the circulation. J Appl Physiol 91:1708-1712., 2001.
214. Steensberg A, Toft AD, Schjerling P, Halkjaer-Kristensen J, and Pedersen BK. Plasma interleukin-6 during strenuous exercise: role of epinephrine. Am J Physiol Cell Physiol 281:C1001-C1004, 2001.
215. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, and Pedersen BK. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529:237-242, 2000.
216. Stow JL, and Murray RZ. Intracellular trafficking and secretion of inflammatory cytokines. Cytokine Growth Factor Rev 24:227-239, 2013.
217. Struyf S, Van Collie E, Paemen L, Put W, Lenaerts JP, Proost P, Opdenakker G, and Van Damme J. Synergistic induction of MCP-1 and -2 by IL-1β and interferons in fibroblasts and epithelial cells. J Leukoc Biol 63:364-372, 1998.
218. Summan M, Warren GL, Mercer RR, Chapman R, Hulderman T, Van Rooijen N, and Simeonova PP. Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am J Physiol Regul Integr Comp Physiol 290:R1488-1495, 2006.
219. Suzuki K, Nakaji S, Yamada M, Liu Q, Kurakake S, Okamura N, Kumae T, Umeda T, and Sugawara K. Impact of a competitive marathon race on systemic cytokine and neutrophil responses. Med Sci Sports Exerc 35:348-355, 2003.
220. Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, and Sugawara K. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 8:6-48, 2002.
221. Suzuki K, Nakajima H, Ikeda K, Maezawa Y, Suto A, Takatori H, Saito Y, and Iwamoto I. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-α production in mast cells. J Exp Med 198:1717-1727, 2003.
222. Taganov KD, Boldin MP, Chang KJ, and Baltimore D. NF-κBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481-12486, 2006.
223. Tiku K, Tiku ML, and Skosey JL. Interleukin 1 production by human polymorphonuclear neutrophils. J Immunol 136:3677-3685, 1986.
224. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, and Croce CM. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179:5082-5089, 2007.
225. Toft AD, Jensen LB, Bruunsgaard H, Ibfelt T, Halkjaer-Kristensen J, Febbraio M, and Pedersen BK. Cytokine response to eccentric exercise in young and elderly humans. Am J Physiol Cell Physiol 283:C289-C295, 2002.
226. Tomiya A, Aizawa T, Nagatomi R, Sensui H, and Kokubun S. Myofibers express IL-6 after eccentric exercise. Am J Sports Med 32:503-508, 2004.
227. Trendelenburg AU, Meyer A, Jacobi C, Feige JN, and Glass DJ. TAK-1/p38/NFκB signaling inhibits myoblast differentiation by increasing levels of Activin A. Skelet Muscle 2:3, 2012.
228. van de Vyver M, and Myburgh KH. Variable inflammation and intramuscular STAT3 phosphorylation and myeloperoxidase levels after downhill running. Scand J Med Sci Sports 24:e360-71, 2014.
229. Vasudevan S, Tong Y, and Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 318:1931-1934, 2007.
230. Vona-Davis L, Frankenberry K, Lebedeva K, and McFadden DW. LPS and TNF-α induce SOCS-3 mRNA expression in cardiac myoblasts. Shock 21:38-38, 2004.
231. Weinstock C, Konig D, Harnischmacher R, Keul J, Berg A, and Northoff H. Effect of exhaustive exercise stress on the cytokine response. Med Sci Sports Exerc 29:345-354, 1997.
232. Welc SS, and Clanton TL. The regulation of interleukin-6 implicates skeletal muscle as an integrative stress sensor and endocrine organ. Exp Physiol 98:359-371, 2013.
233. Welc SS, Judge AR, and Clanton TL. Skeletal muscle interleukin-6 regulation in hyperthermia. Am J Physiol Cell Physiol 305:C406-413, 2013.
234. Welc SS, Phillips NA, Oca-Cossio J, Wallet SM, Chen DL, and Clanton TL. Hyperthermia increases interleukin-6 in mouse skeletal muscle. Am J Physiol Cell Physiol 303:C455-466, 2012.
235. Whitham M, Chan MH, Pal M, Matthews VB, Prelovsek O, Lunke S, El-Osta A, Broenneke H, Alber J, Bruning JC, Wunderlich FT, Lancaster GI, and Febbraio MA. Contractioninduced IL-6 gene transcription in skeletal muscle is regulated by c-jun terminal kinase/Activator protein-1. J Biol Chem 287:10771-10779, 2012.
236. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, and Achong MK. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101:311-320, 1998.
237. Yahiaoui L, Gvozdic D, Danialou G, Mack M, and Petrof BJ. CC chemokines directly regulate myoblast responses to skeletal muscle injury. J Physiol 586:3991-4004, 2008.
238. Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, and Stern D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 270:11463-11471, 1995.
239. Zaldivar F, Wang-Rodriguez J, Nemet D, Schwindt C, Galassetti P, Mills PJ, Wilson LD, and Cooper DM. Constitutive pro- and anti-inflammatory cytokine and growth factor response to exercise in leukocytes. J Appl Physiol 100:1124-1133, 2006.
240. Zhang L, Lee JE, Wilusz J, and Wilusz CJ. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J Biol Chem 283:22457-22463, 2008.